Treeline

Treeline Biosciences is a biotechnology company focused on the discovery and development of small molecule medicines for oncology and other serious diseases. Founded by industry veterans Josh Bilenker and Jeff Engelman, the company utilizes a multi-disciplinary platform that integrates structural biology, medicinal chemistry, and computational science to target difficult-to-drug proteins. Treeline specifically focuses on protein dynamics and allosteric regulation to identify new therapeutic opportunities. The company is headquartered in Stamford, Connecticut, with additional research facilities in Watertown, Massachusetts, and San Diego, California. Treeline is currently in the pre-clinical stage with a pipeline of programs targeting high-value cancer pathways.